Date of publication:
This is a recording of a live webinar that took place on Thursday 8 July 2021. This recording will be available to view until 10 February 2022.
This conference explores how obesity impacts significantly on many organs resulting in common disease clusters that have a metabolic or inflammatory component. COVID-19 has thrown a particular spotlight on obesity as a risk factor for poorer outcomes. We reviewed the healthcare challenges of living with multi-morbidity and how primary care might streamline some components of care.
- Explore why the prothrombotic inflammatory effects of COVID-19 result in poorer outcomes for people with obesity
- Review the role of obesity and weight reduction across different end-organs, including fertility and liver health
- Understand how medical and surgical obesity treatments affect end-organ health
- Consider how healthcare systems can be modified to reduce the treatment burden associated with having several long-term conditions